Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Mycol Med ; 27(3): 351-356, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28483449

ABSTRACT

Aspergillus terreus is the fourth leading cause of invasive and non-invasive aspergillosis and one of the causative agents of morbidity and mortality among immunocompromised and high-risk patients. A. terreus appears to have increased as a cause of opportunistic fungal infections from superficial to serious invasive infections. Although, invasive aspergillosis is often treated empirically with amphotericin B, most A. terreus isolates are resistant both in vivo and in vitro to some antifungal drugs. In this study, we aimed to evaluate antifungals susceptibility profiles of the different strains of A. terreus against amphotericin B, caspofungin, fluconazole, voriconazole, posaconazole and luliconazole. Forty A. terreus strains originating from environmental sources (air and soil) were identified using by macroscopic and microscopic features. Six antifungals including, amphotericin B, caspofungin, fluconazole, voriconazole, posaconazole and luliconazole were applied for susceptibility tests. Our results show that tested isolates had different susceptibility to antifungals. The lowest MICGM related to luliconazole (0.00236µg/ml), followed by posaconazole (0.18621µg/ml), voriconazole (0.22925µg/ml), caspofungin (0.86µg/ml), fluconazole (8µg/ml) and amphotericin B (11.12µg/ml). This study demonstrated that luliconazole had an excellent in vitro activity against all tested isolates of A. terreus, with MICGM 0.00236µg/mL than other tested antifungals. As a result, luliconazole could be a possible alternative antifungal for the treatment of aspergillosis due to A. terreus.


Subject(s)
Antifungal Agents/pharmacology , Aspergillus/drug effects , Imidazoles/pharmacology , Aspergillosis/drug therapy , Aspergillosis/microbiology , Aspergillus/physiology , Drug Resistance, Fungal/drug effects , Humans , Imidazoles/therapeutic use , Microbial Sensitivity Tests , Opportunistic Infections/drug therapy , Opportunistic Infections/microbiology
2.
J Biol Regul Homeost Agents ; 26(2): 231-6, 2012.
Article in English | MEDLINE | ID: mdl-22824750

ABSTRACT

Carbapenems are the most potent beta-lactam agents with a broad-spectrum activity against Gram-negative and Gram-positive bacteria. They are stable in the presence of penicillinases and cephalosporinases. This study was focused on frequency of metallo beta- lactamase (MBL) among Pesudomonas aeruginosa strains isolated in patients with urinary tract infection, effect of tannin against PA positive strains which produced blaVIM or blaIMP and both of these genes (Species). Detection of MBL was performed by phonotypic and genotypic methods. Tannin extract was tested against P. aeruginosa producing MBL. During the study period, 240 P. aeruginosa isolates were identified. Among them 64 (26.6 percent) isolates were imipenem non-susceptible and confirmed by imipenem/EDTA. Our results revealed that the growth of blaVIM positive P. aeruginosa inhibited at 15 microg/ml concentration. The experiment repeated for blaIMP-positive P. aeruginosa and P. aeruginosa which harbored blaIMP and blaVIM, the results showed 35 microg/ml was the best concentration for inhibition of P. aeruginosa-positive blaIMP and also P. aeruginosa blaIMP and blaVIM. In conclusion, tannin was effective against P. aeruginosa producing blaVIM and blaIMP and both of them so it can be substituted with common antibiotics. The result showed significantly P. aeruginosa-harbored blaIMP was more responsible for imipenem resistance than P. aeruginosa-positive blaVIM. Interestingly, tannin was more effective against MBL-P. aeruginosa in comparison with current antibiotics.


Subject(s)
Pseudomonas aeruginosa/drug effects , Tannins/pharmacology , Urinary Tract Infections/microbiology , beta-Lactamases/biosynthesis , Animals , Chlorocebus aethiops , Humans , Imipenem/pharmacology , Pseudomonas aeruginosa/enzymology , Pseudomonas aeruginosa/growth & development , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...